Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$619,392,956
-$8,284,231 QoQ
Shares Held
2,438,843
-5.0% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#86
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $3,027,251,343 across 9 Drug Manufacturers - General names. JNJ ranks #2 (20.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
640,845 | $768,648,782 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
2,438,843 | $619,392,956 | |
| 3 | ABBV |
AbbVie Inc.
|
1,761,265 | $443,204,724 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,816,256 | $361,888,896 | |
| 5 | AZN |
Astrazeneca PLC
|
1,526,363 | $289,428,952 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,648,030 | $208,212,110 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,765,830 | $159,367,124 | |
| 8 | PFE |
Pfizer Inc
|
6,258,004 | $150,692,736 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $619,392,956 | 2,438,843 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $627,677,187 | 2,567,817 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $548,236,832 | 2,649,127 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $580,179,920 | 3,129,004 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $450,743,558 | 2,950,858 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $480,266,669 | 2,895,964 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $407,299,523 | 2,816,343 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $540,002,231 | 3,332,113 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $476,083,313 | 3,257,275 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $485,485,899 | 3,069,005 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $459,123,591 | 2,929,205 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $447,687,487 | 2,874,398 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $546,245,130 | 3,300,176 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $532,701,055 | 3,436,781 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $612,599,765 | 3,467,873 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $538,199,974 | 3,294,564 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $584,464,276 | 3,292,571 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $570,243,018 | 3,217,531 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $552,562,600 | 3,230,038 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $384,993,389 | 2,383,860 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $435,226,111 | 2,641,897 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $430,169,688 | 2,617,400 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $467,390,742 | 2,969,823 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $417,861,791 | 2,806,702 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $411,037,861 | 2,922,832 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $442,263,327 | 3,372,709 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||